What is PranaQ?
PranaQ specializes in home sleep apnea diagnostics and monitoring, offering a cloud-based solution that ensures FDA-cleared accuracy and simplicity. The company's products eliminate the need for invasive testing equipment, providing a hassle-free experience for both clinicians and patients. PranaQ assists healthcare providers in expanding their home sleep apnea testing (HSAT) services while reducing in-lab testing backlogs. Its intended clients include sleep medicine specialists, telehealth practices, and healthcare facilities seeking efficient and scalable sleep diagnostic solutions. By digitizing the diagnostic process, PranaQ effectively bridges the gap between patient convenience and clinical precision.
How much funding has PranaQ raised?
PranaQ has raised a total of $3M across 1 funding round:
Angel/Seed
$3M
Angel/Seed (2022): $3M with participation from Lighthouse Combined Investment, DSC Investment, and NAVER D2SF
Key Investors in PranaQ
Lighthouse Combined Investment
A venture capital firm established by mid-sized manufacturing companies in South Korea, focusing on fostering collaborative growth between startups and established industrial enterprises.
DSC Investment
A prominent investment firm that supports high-growth startups through strategic capital and operational expertise, often focusing on technology-driven sectors.
NAVER D2SF
The corporate venture capital arm of NAVER, specializing in early-stage investments in deep-tech and healthcare startups that align with their digital ecosystem.
What's next for PranaQ?
With the recent capital injection, PranaQ is poised to scale its diagnostic platform to meet the rising demand for remote patient monitoring. The strategic focus will likely center on enhancing the cloud-based analytics engine to provide deeper insights for sleep medicine specialists, thereby increasing the value proposition for telehealth practices. Furthermore, the company is expected to leverage its partnerships with institutional investors to navigate regulatory landscapes and broaden its market reach. As the healthcare industry continues to prioritize cost-effective, home-based diagnostic alternatives, PranaQ's ability to integrate seamlessly into existing clinical workflows will be a primary driver of its long-term growth trajectory.
See full PranaQ company page
